Furthermore, dual incretin agonists like tirzepatide exhibit superior efficacy, not only in reducing adipocyte size and visceral fat volume, but also in promoting BAT thermogenesis
What remains intriguing is this: after so many hard lessons learned from building around GLP-1 (the peptide of the decade) many founders still don't recognize that healthcare demands certain non-negotiable considerations: technology, regulation, and clinical expertise
Wife asked if I was feeling ok because Ive never turned down cake in 30 years of marriage
Liposuction results are permanent, whereas Ozempic results are temporary and heavily rely on continued use
Treatment adjustments don't affect your monthly cost, allowing you to focus on health rather than pricing surprises
GIP and GLP-1, the two incretin hormones: similarities and differences